N

Nektar Therapeutics
D

NKTR

25.020
USD
0.42
(1.71%)
مغلق
حجم التداول
28,750
الربح لكل سهم
-12
العائد الربحي
-
P/E
-3
حجم السوق
432,859,085
أصول ذات صلة
A
ALKS
-0.410
(-1.55%)
26.120 USD
AMGN
AMGN
-2.01
(-0.65%)
306.66 USD
BIIB
BIIB
-1.010
(-0.76%)
131.630 USD
BMRN
BMRN
-0.765
(-1.28%)
59.010 USD
GILD
GILD
3.000
(2.65%)
116.210 USD
INCY
INCY
-0.300
(-0.43%)
70.180 USD
LLY
LLY
8.95
(1.11%)
812.95 USD
MRK
MRK
0.570
(0.68%)
84.730 USD
PFE
PFE
-0.555
(-2.19%)
24.810 USD
REGN
REGN
-1.20
(-0.21%)
563.22 USD
المزيد
الأخبار المقالات

العنوان: Nektar Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.